Carmignac Gestion 13D/13G Filings for Clearside Biomedical, Inc. (CLSD)

Carmignac Gestion 13D and 13G filings for Clearside Biomedical, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-13
12:19 pm
Sale
2022-12-3113GCLEARSIDE BIOMEDICAL INC
CLSD
Carmignac Gestion160,023
3.980%
-48,260decrease
(-23.17%)
Filing
2022-02-09
2:09 pm
Sale
2021-12-3113GCLEARSIDE BIOMEDICAL INC
CLSD
Carmignac Gestion208,283
5.200%
-27,781decrease
(-11.77%)
Filing